Semenova Ekaterina, Guo Alex, Liang Harry, Hernandez Cindy J, John Ella B, Thaker Vidhu V
Division of Molecular Genetics, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY, USA.
Vagelos College of Physicians and Surgeons, Columbia University, New York, NY, USA.
Pediatr Res. 2024 Dec 17. doi: 10.1038/s41390-024-03780-6.
Obesity and weight regulation disorders are determined by the combined effects of genetics and environment. Polygenic obesity results from the combination of common variants in several genes which predisposes the individual to obesity and its related complications. In contrast, monogenic obesity results from changes in single genes, especially those in leptin-melanocortin pathway, and presents with early onset severe obesity, with or without other syndromic features. Rare variants in melanocortin 4 receptor are the commonest form of monogenic obesity. In addition, structural variation in small or large segments of chromosomes may also present with syndromic forms of obesity. Prader-Willi Syndrome, caused by imprinting errors in chromosome 15q11-13, is the most prevalent genetic cause of severe hyperphagia and obesity. With the advances in technologies, the past decade has witnessed a revolution in the identification of novel genetic causes of obesity, primarily in genes related to the leptin melanocortin pathway. The availability of safe melanocortin analogs holds the potential for targeted therapies for some of these disorders. This review summarizes known and novel rare genetic forms of obesity, along with approaches for the clinical investigation of copy number and sequence variants. The goal is to provide a reference for practicing clinicians to encourage genetic testing in obesity. IMPACT: What does this article add to the existing literature? Genetic obesity is an expanding frontier with potential to change management. Here, we summarize current information on the genetic causes of obesity and provide guidance for genetic testing. Emerging treatments may provide targeted precise treatment and change management practices.
肥胖和体重调节障碍是由遗传和环境的综合作用决定的。多基因肥胖是由多个基因中的常见变异组合而成,这些变异使个体易患肥胖及其相关并发症。相比之下,单基因肥胖是由单个基因的变化引起的,尤其是那些在瘦素 - 黑皮质素途径中的基因,表现为早发性严重肥胖,伴有或不伴有其他综合征特征。黑皮质素4受体的罕见变异是单基因肥胖最常见的形式。此外,染色体小片段或大片段的结构变异也可能表现为综合征形式的肥胖。普拉德 - 威利综合征由15q11 - 13染色体上的印记错误引起,是严重贪食和肥胖最常见的遗传原因。随着技术的进步,在过去十年中,肥胖新遗传原因的识别发生了一场革命,主要集中在与瘦素 - 黑皮质素途径相关的基因上。安全的黑皮质素类似物的可用性为其中一些疾病的靶向治疗带来了潜力。这篇综述总结了已知的和新发现的罕见肥胖遗传形式,以及拷贝数和序列变异的临床研究方法。目的是为临床医生提供参考,以鼓励对肥胖进行基因检测。影响:本文为现有文献增添了什么?遗传性肥胖是一个不断扩展的前沿领域,有可能改变治疗方式。在这里,我们总结了肥胖遗传原因的当前信息,并为基因检测提供指导。新兴的治疗方法可能提供靶向精准治疗并改变治疗方式。